CDCA2 and lip and oral cavity carcinoma: Consistent with these clinical findings, experiments on oral cancer cell lines showed that suppression of CDCA2 expression with shRNA significantly inhibits cellular proliferation by arresting cell-cycle progression at the G1 phase and inducing apoptotic cell death by treatment with CDDP through activation of the DDR of these OSCC cells in vitro.